Built for Safe, Reliable Results. Trusted by Clinics Worldwide
STEM Nova ethically produces and independently tests U.S.-made 3D UCT‑MSCs and Exosome+™ in our cGMP‑certified facility, delivering clinical‑grade cells and exosomes with unmatched potency, safety, viability, and full regulatory compliance for clinics and research teams.
Xeno Free Exosomes
Manufactured without animal-derived components and designed to support immune compatibility. This approach reduces biologic risk, improves consistency, and aligns with clinical-grade manufacturing standards
3D Culture, 20x Potency
Produced in our 3D bioreactor culture system, which replicates the natural cellular environment, producing significantly higher secretome and exosome output than traditional 2D methods. For clinics, this delivers more biologically active signaling per treatment—supporting consistency, potency, and clinical-grade reliability.
98% Post-Thaw Viability
Validated cryopreservation and handling protocols preserve cellular integrity after thaw. This supports consistent dosing, predictable handling, and reliable clinical use.
Ethically Sourced UCT Stem Cells
Derived from ethically donated umbilical cord tissue under AATB-accredited standards and documented within an FDA Type II Master File. Donor eligibility, going 3 generations back, includes a comprehensive medical history review, infectious disease screening, and genetic risk assessment to support clinical-grade manufacturing integrity.
Whartons Jelly UCT-MSCs
Wharton's Jelly Umbilical cord–derived MSCs are biologically younger, highly proliferative, and naturally immune-privileged. Compared to adipose-derived stem cells sources, they offer a cleaner, more consistent cell population to support reliable clinical applications.
Live Cryopreserved Cells
Cryopreservation preserves cellular viability, membrane integrity, and active paracrine signaling—allowing native extracellular vesicles and growth-factor cargo to resume biologic function after thaw. In contrast, most exosome products on the market are freeze-dried for convenience, a process that irreversibly degrades structure, bioactivity, and signaling consistency. By never lyophilizing, we preserve native membranes and cargo to support reliable uptake, biologic relevance, and clinical
Multipotent UCT-MSCs
Multipotent mesenchymal stem cells (MSCs) can differentiate into multiple specialized cell types within defined lineages, including bone, cartilage, muscle, and connective tissue. Our umbilical cord–derived MSCs are manufactured for clinical-grade consistency, supporting regenerative signaling without the limitations of terminally differentiated cells
Third Party Tested & Full Traceability
Each batch undergoes third-party testing, including Nanoparticle Tracking Analysis (NTA), to verify exosome concentration, size distribution, and consistency. Full lot traceability is maintained through AATB-accredited sourcing and documented quality systems, supporting batch-level accountability and clinical-grade assurance.
The Next Competitive Advantage in Human Performance
From elite athletes to advanced clinical applications, the future belongs to regenerative medicine.
Stem Nova develops and delivers validated, clinical-grade biologics through rigorously controlled processes—built for those who demand measurable outcomes and uncompromising quality.
Clinical-grade biologics trusted by leading practitioners
End-to-end manufacturing of 3D-cultured UCT-MSC biologics designed to deliver consistent secretome output, verified exosome content, and clinically reliable performance. Built on controlled bioreactor systems and analytical validation, our platform supports reproducibility, traceability, and confidence in clinical use.
JOIN 1,000+ LICENSED PROVIDERS NATIONWIDE
Stem Nova supplies clinical-grade 3D-cultured exosomes and UCT-MSCs exclusively to licensed medical professionals. Enrollment takes minutes. Access wholesale pricing, CoAs, NTA data, and dedicated support from day one.
FAQs
We’ve compiled answers to the most common inquiries about our stem cell and exosome products, from safety and usage to regulatory compliance and clinical applications.
Are STEM Nova Network biologics FDA‑approved?
No. Our 3D UCT‑MSC and exosome products are manufactured in FDA‑registered, ISO‑compliant facilities under cosmetic good‑manufacturing practices, but they are not FDA‑approved drugs or biologics. The U.S. Food and Drug Administration states that exosome products intended to treat diseases or conditions in humans require FDA approval and “there are currently no FDA‑approved exosome products”. We strictly market our products for research or topical cosmetic use and do not make medical claims.
What makes 3D‑cultured MSCs better than traditional 2D?
Three‑dimensional culture mimics the body’s natural environment and dramatically increases exosome production and potency. In a hollow‑fiber 3D bioreactor, MSCs produced up to 19.4‑fold more exosomes than in a standard 2D flask, and the supernatants were 15.5‑fold more concentrated. 3D culture also allows continuous harvesting of exosomes, requires far fewer plastic flasks and less labour, and can produce an equivalent yield in less than 30 minutes per day. These 3D‑derived exosomes show superior uptake by target cells and stronger effects .compared with 2D exosomes.
These 3D-derived exosomes demonstrate superior biological signaling profiles and cellular uptake characteristics compared with 2D exosomes, supporting the enhanced potency behind our 3DExo+™ platform
Can I inject these biologics?
Stem Nova biologics are manufactured to pharmaceutical-grade quality standards, including sterility, endotoxin, and viability testing. They are labeled for topical and research use only. Any clinical application is at the sole discretion and professional responsibility of the licensed practitioner, in accordance with all applicable federal and state regulations.
Who are Stem Nova's products intended for?
Stem Nova biologics are supplied exclusively to licensed medical professionals. How products are used within a practitioner's clinical protocols is at their sole discretion and in accordance with applicable federal and state regulations. We do not advise on indications, applications, or patient protocols.
What does “xeno‑free ”mean?
“Xeno‑free” means that all components are derived from the same species (human) or are recombinant, so no animal‑derived ingredients such as fetal bovine serum are present. RegMedNet explains that xeno‑free media contain only proteins of human origin or recombinant quality. Using xeno‑free, serum‑free manufacturing reduces the risk of introducing foreign proteins or pathogens, making the product safer and more consistent for cosmetic or research use.
Disclaimer
Stem Nova Network supplies professional-grade, cell-free biologic matrices exclusively to licensed medical professionals. These products are not FDA-approved drugs or therapeutic agents and are not intended to diagnose, treat, cure, or prevent any disease or condition. No exosome or MSC-derived biologic product currently holds FDA approval for therapeutic use in humans.
All product use is at the sole clinical discretion and professional responsibility of the licensed practitioner. Stem Nova Network does not provide medical advice, clinical protocols, or treatment guidance of any kind.
